Quality Innovation Group

EMA Veterinary Medicines Info Day 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 March 2026, 14:00 (CET) to 13 March 2026, 12:30 (CET)

Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Human medicines European public assessment report (EPAR): Elfabrio, pegunigalsidase alfa, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised

Referral: Melatomed and associated names, melatonin Article 29(4) referrals European Commission final decision, 11/12/2025, 18/02/2026, 17/03/2026

Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 21, Status: Authorised

Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (X-39)

Human medicines European public assessment report (EPAR): Plegridy, peginterferon beta-1a, Date of authorisation: 18/07/2014, Revision: 30, Status: Authorised

PSUSA/00010502/202507